[Circulating inhibitor of erythropoiesis in patients with acquired aplastic anemia].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000741:Anemia, Aplastic / Q000276:immunology* / Q000628:therapy; D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology; D001798:Blood Proteins / Q000032:analysis*; D003131:Combined Modality Therapy; D004920:Erythropoiesis; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008875:Middle Aged; D010956:Plasmapheresis
D001323:Autoantibodies; D001798:Blood Proteins; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; C007627:erythropoiesis inhibiting factors
Inhibidor circulante de la eritropoyesis en pacientes con anemia aplástica adquirida.